Guided Therapeutics, Inc. Stock
Stocks
GTHP
US40171F5017
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2290 USD | -.--% |
|
-18.19% | -57.59% |
| 07-14 | Guided Therapeutics, Inc. Announces New Agreement With Yuanshuo Medical Instruments Corporation | CI |
| 06-16 | Guided Therapeutics Files Premarket Approval Application Clinical Report with FDA | CI |
| Market Cap | 25.1M 22.08M 20.51M 18.86M 35.37M 2.43B 36.01M 245M 95.65M 1.19B 94.23M 92.19M 4.11B | P/E 2024 |
-3x | P/E 2025 | -12.7x |
|---|---|---|---|---|---|
| Enterprise Value | 27.98M 24.6M 22.86M 21.02M 39.42M 2.71B 40.13M 273M 107M 1.32B 105M 103M 4.58B | EV / Sales 2024 |
1,649x | EV / Sales 2025 | 64.4x |
| Free-Float |
63.48% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 week | -18.19% | ||
| Current month | -4.58% | ||
| 1 month | -11.92% | ||
| 3 months | +14.50% | ||
| 6 months | -41.28% | ||
| Current year | -57.59% |
| 1 week | 0.2 | 0.28 | |
| 1 month | 0.2 | 0.32 | |
| Current year | 0.17 | 0.54 | |
| 1 year | 0.12 | 0.54 | |
| 3 years | 0.06 | 0.54 | |
| 5 years | 0.06 | 0.78 | |
| 10 years | 0.02 | 3,200 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mark Faupel
CEO | Chief Executive Officer | 70 | 2023-03-05 |
| Chief Tech/Sci/R&D Officer | 70 | 2010-12-01 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Faupel
BRD | Director/Board Member | 70 | 2016-11-30 |
John Imhoff
BRD | Director/Board Member | 76 | 2006-04-09 |
Michael James
CHM | Chairman | 67 | 2013-09-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 3/10/26 | Others | Director | 10 | 0.9747% | ||
| 3/10/26 | Free | Chairman | 110,000 | 0.1316% | ||
| 3/10/26 | Free | Director | 110,000 | 0.1316% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -18.19% | -3.90% | +68.26% | 26.07M | ||
| +8.71% | +5.36% | +22.63% | +1.80% | 196B | ||
| +7.46% | -6.10% | -2.72% | -24.77% | 126B | ||
| -2.54% | -17.48% | -33.85% | -1.38% | 120B | ||
| +1.42% | -2.33% | -59.56% | -18.02% | 63.87B | ||
| -0.65% | -4.58% | +8.98% | -9.45% | 48.58B | ||
| -1.56% | -3.21% | -26.85% | -33.72% | 43.93B | ||
| +4.71% | +2.67% | +16.97% | +9.50% | 37.69B | ||
| +3.13% | +1.12% | +29.35% | +32.45% | 36.41B | ||
| +3.14% | +3.47% | +88.18% | +3.34% | 28.88B | ||
| Average | +2.10% | -3.03% | +3.92% | +2.80% | 70.13B | |
| Weighted average by Cap. | +3.61% | -5.06% | -0.40% | -6.25% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 7K 6.16K 5.72K 5.26K 9.86K 678K 10.04K 68.39K 26.68K 331K 26.28K 25.71K 1.15M | 767K 675K 627K 576K 1.08M 74.28M 1.1M 7.49M 2.92M 36.23M 2.88M 2.82M 126M |
| Net income | -2.42M -2.13M -1.97M -1.82M -3.41M -234M -3.47M -23.61M -9.21M -114M -9.07M -8.88M -396M | -3.2M -2.81M -2.61M -2.4M -4.5M -310M -4.58M -31.23M -12.18M -151M -12M -11.74M -524M |
| Net Debt | 1.77M 1.56M 1.45M 1.33M 2.5M 172M 2.54M 17.3M 6.75M 83.65M 6.65M 6.5M 290M | 2.88M 2.53M 2.35M 2.16M 4.05M 279M 4.13M 28.1M 10.96M 136M 10.8M 10.56M 471M |
Employees
3
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-23 | US$0.2600 | -3.70% | 5,100 |
| 26-07-22 | US$0.2700 | -0.47% | 310 |
| 26-07-21 | US$0.2713 | -1.35% | 5,500 |
| 26-07-20 | US$0.2750 | -1.75% | 2,200 |
| 26-07-16 | US$0.2799 | +3.67% | 573 |
- Stock Market
- Stocks
- GTHP Stock
Select your edition
All financial news and data tailored to specific country editions
















